Biologic drugs for analgesia: redefining the opportunity

Related Experiment Video

Updated: Jun 3, 2026

Development of Recombinant Proteins to Treat Chronic Pain
10:37

Development of Recombinant Proteins to Treat Chronic Pain

Published on: April 11, 2018

Jane Hughes1, Jonathan P Hatcher, Iain P Chessell

  • 1MedImmune Ltd, Granta Park, Cambridge CB21 6GH, UK.

Current Pharmaceutical Biotechnology
|April 7, 2011
PubMed

Insights

Biologic therapies, like monoclonal antibodies, offer highly selective treatment options for chronic pain. These advanced therapies promise improved pain relief and fewer side effects than traditional treatments.

Area of Science:

  • Pain research and therapeutics
  • Immunology
  • Pharmacology

Background:

  • Chronic pain, including inflammatory and neuropathic pain, significantly burdens society and is inadequately managed by current treatments.
  • Existing therapies often cause side effects and fail to provide sufficient pain relief for many patients.
  • Developing novel pain therapies is crucial, but challenges like off-target effects in small molecule approaches hinder clinical testing.

Purpose of the Study:

  • To review the current status and future potential of biologic therapies for chronic pain management.
  • To highlight the advantages of biologic agents, such as monoclonal antibodies, in providing targeted pain relief.
  • To explore the broader landscape of biologic approaches, including peptides, for novel pain interventions.

Main Methods:

  • Review of current scientific literature on biologic therapies for pain.
  • Analysis of the selectivity and efficacy of monoclonal antibodies in preclinical and clinical studies.
  • Exploration of emerging biologic strategies, including peptide-based therapeutics.

Main Results:

  • Biologic therapies, particularly monoclonal antibodies, demonstrate exquisite selectivity, minimizing off-target effects common in small molecule drug development.
  • Successful application of antibody therapeutics in immunology and cancer suggests similar transformative potential for pain management.
  • Recent advancements indicate that biologics could revolutionize pain treatment paradigms, akin to their impact in conditions like rheumatoid arthritis.

Conclusions:

  • Biologic therapies represent a promising frontier for treating chronic pain, offering enhanced selectivity and potentially greater efficacy.
  • Monoclonal antibodies and other biologic approaches, such as peptides, are poised to overcome limitations of current pain treatments.
  • Further development and clinical application of biologic therapies are essential to address the unmet needs in chronic pain management.

More Related Videos

Determining Pain Detection and Tolerance Thresholds Using an Integrated, Multi-Modal Pain Task Battery09:38

Determining Pain Detection and Tolerance Thresholds Using an Integrated, Multi-Modal Pain Task Battery

Published on: April 14, 2016

Intracranial Pharmacotherapy and Pain Assays in Rodents02:26

Intracranial Pharmacotherapy and Pain Assays in Rodents

Published on: April 9, 2019

Related Concept Videos

Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
Drug Products: Biologics, Biosimilars and Interchangeables01:28

Drug Products: Biologics, Biosimilars and Interchangeables

Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
Principles of Drug Action01:24

Principles of Drug Action

Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...